Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: Time dependence of peroxidative injury

被引:39
作者
Raza, M
AlBekairi, AM
Ageel, AM
Qureshi, S
机构
[1] Department of Pharmacology, College of Pharmacy, Riyadh, 11451
关键词
sodium valproate; lipid peroxidase; glutathione;
D O I
10.1006/phrs.1997.0134
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mice fed with sodium valproate for 7, 14 and 21 days were evaluated for hepatotoxicity and renal tubular disorder. The drug was administered as an aqueous solution with an increasing concentration up to five days gradually reaching up to 0.71% w/v, which persisted throughout the study period. Mice fed with sodium valproate for 7, 14 and 21 days showed, marked hepatic injury and renal tubular disorder, evidenced by increased levels of malondialdehyde as a measure of lipid peroxidation. Administration of sodium valproate affected the glutathione contents both in liver and kidney tissue at all the three time points. However, this reduction in glutathione concentration was more pronounced in kidney when compared to control group. These results support the hypothesis that lipid peroxidation mediates the effect of sodium valproate on liver and kidney. Furthermore, the valproate induced toxicity is time related and the increase in lipid peroxide levels and depletion of glutathione occur time dependent even if the dose is clinically appropriate. (C) 1997 The Italian Pharmacological Society.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 38 条
[1]   METABOLISM OF VALPROATE TO HEPATOTOXIC INTERMEDIATES [J].
BAILLIE, TA .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1992, 14 (3A) :122-125
[2]  
BEUTLER E, 1974, GLUTATHIONE, P109
[3]   PROTECTION AGAINST SODIUM VALPROATE INJURY IN ISOLATED HEPATOCYTES BY ALPHA-TOCOPHEROL AND "N,N'-DIPHENYL-PARA-PHENYLENEDIAMINE [J].
BUCHI, KN ;
GRAY, PD ;
ROLLINS, DE ;
TOLMAN, KG .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (04) :148-154
[4]   STANDARD APPROACH TO ANTIEPILEPTIC DRUG-TREATMENT IN THE UNITED-KINGDOM [J].
CHADWICK, D .
EPILEPSIA, 1994, 35 :S3-S10
[5]  
Chadwick D, 1988, Am J Med, V84, P3, DOI 10.1016/0002-9343(88)90049-6
[6]   MECHANISM OF ANTI-CONVULSANT ACTION OF VALPROATE [J].
CHAPMAN, A ;
KEANE, PE ;
MELDRUM, BS ;
SIMIAND, J ;
VERNIERES, JC .
PROGRESS IN NEUROBIOLOGY, 1982, 19 (04) :315-359
[7]   VALPROIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN EPILEPSY [J].
DAVIS, R ;
PETERS, DH ;
MCTAVISH, D .
DRUGS, 1994, 47 (02) :332-372
[8]   VALPROIC ACID HEPATIC FATALITIES - A RETROSPECTIVE REVIEW [J].
DREIFUSS, FE ;
SANTILLI, N ;
LANGER, DH ;
SWEENEY, KP ;
MOLINE, KA ;
MENANDER, KB .
NEUROLOGY, 1987, 37 (03) :379-385
[9]   LESIONS AND REPAIR OF CELLS OF MATERNAL MICE AFTER VALPROIC ACID (VPA) TREATMENT ON DAY 8 OF PREGNANCY - AN ENZYME HISTOCHEMICAL ANALYSIS [J].
GOSSRAU, R ;
GRAF, R .
ACTA HISTOCHEMICA, 1989, 86 (01) :23-32
[10]  
HJELM M, 1986, LANCET, V2, P859